Further, clinically the high response rate is not always observed among patients with high neoantigen load, PD-L1 expression or antigen intensity, and the correlations between each factor and the tumour response are also different among the different subtypes of breast cancer [2]. This evidence concerns the gene CD274 and neoplasm.